Showing results (2181-2190 of 2,380) with videos related to

Sort By:
Pageof 238
Investigational New Drugs|October 27, 2016
Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)Kit Man Wong, Lindsey N Micel, Heather M Selby, et al.
Neuromodulation : Journal of the International Neuromodulation Society|March 8, 2024
Examining the Duration of Carryover Effect in Patients With Chronic Pain Treated With Spinal Cord Stimulation (EChO Study): An Open, Interventional, Investigator-Initiated, International Multicenter StudyKaare Meier, Cecile C de Vos, Martine Bordeleau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignanciesC D Britten, E K Rowinsky, S D Baker, et al.
Critical Care Medicine|September 28, 2021
Physiological Assessment of Delirium Severity: The Electroencephalographic Confusion Assessment Method Severity Score (E-CAM-S)Meike van Sleuwen, Haoqi Sun, Christine Eckhardt, et al.
Molecular Cancer Therapeutics|October 7, 2010
Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancerJohn J Tentler, Sujatha Nallapareddy, Aik Choon Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumorsMichael S Gordon, Christopher S Sweeney, David S Mendelson, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2024
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trialAnna M Mc Laughlin, Dagmar Hess, Robin Michelet, et al.
Pageof 238